Thomas Reed - Intrexon Insider

Intrexon Corporation -- USA Stock  

USD 12.26  0.93  7.05%

Founder and Chief Science Officer

Dr. Thomas D. Reed, Ph.D. is Founder, Chief Science Officer of Intrexon Corporationrationration. Dr. Reed cofounded Intrexon in 1998 and has served as Chief Science Officer since then and served on Intrexons board of directors until April 16, 2014. Dr. Reed is a molecular geneticist with over 20 years of experience in recombinant DNA technology. He has developed sophisticated transgenic model systems for studying the role of gene products in neuronal, cardiovascular, and cancer systems. Dr. Reed has published numerous peerreviewed articles in the fields of subcellular modulation, gene regulation and cardiac function and is an inventor on numerous patents
Age: 50  Founder Since 2016      
301 556-9900  www.dna.com
Reed received his B.S. in Genetics from the University of CaliforniaDavis, an M.S. in Biological Science from Wright State University, and a Ph.D. in Molecular and Developmental Biology from the University of Cincinnati.

Thomas Reed Latest Insider Activity

Management Efficiency

The company has Return on Asset of (8.1) % which means that on every $100 spent on asset it lost $8.1. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (21.17) % meaning that it generated no profit with money invested by stockholders.
The company has 8.4 M in debt with debt to equity (D/E) ratio of 1.4 which is OK given its current industry classification. Intrexon Corporation has Current Ratio of 2.4 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Entity Summary

Intrexon Corporationration operates in the synthetic biology field in the United States. Intrexon Corporation (XON) is traded on New York Stock Exchange in USA. It is located in VIRGINIA, U.S.A and employs 640 people. Intrexon is listed under Business Services category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Intrexon Corporation to your portfolio

Top Management

Intrexon Leadership Team
Steven Frank, Director, MBA
Robert Walsh, President
Thomas Kasser, President, MBA
Corey Huck, President
Gregory Frost, CTO, Ph.D
Randal Kirk, Chairman
Andrew Last, COO
Christopher Basta, President
Rick Sterling, CFO
Krish Krishnan, COO, MBA
Cesar Alvarez, Director
Donald Lehr, Executive
Joseph Vaillancourt, President, MBA
Jeffrey Perez, President
Joel Liffmann, President
Larry Horner, Director
Dean Mitchell, Director
Robert Shapiro, Director
Geno Germano, President
Jeffrey Kindler, Director
Jack Bobo, President
Ena Cratsenburg, President, MBA
Thomas Bostick, COO
Samuel Broder, President
Suma Krishnan, President, MBA
Vinita Gupta, Director, MBA
Fred Hassan, Director
James Turley, Director
Darryl Webster, President
Nir Nimrodi, CTO
Thomas Reed, Founder

Stock Performance

Intrexon Performance Indicators